PCM
BRLI

Prelude Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Prelude Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,000
Closed -$169K – 2389
2014
Q4 		$161K Buy
+5,000
New +$145K 0.02% 770
2014
Q3 		– Sell
-3,000
Closed -$91K – 2368
2014
Q2 		$91K Buy
+3,000
New +$82.8K 0.01% 1126
2013
Q4 		– Sell
-4,600
Closed -$137K – 2164
2013
Q3 		$137K Buy
+4,600
New +$128K 0.02% 661

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Prelude Capital Management's BRLI Position: Q1 2015 in Review

Prelude Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2015, closing a stake of 5,000 shares — an estimated $169K sold.

Prelude Capital Management first reported a position in BRLI in Q3 2013 and held it in 3 quarters. The position peaked at $161K in Q4 2014. 168 funds tracked by Wall St. Rank hold BRLI as of Q1 2015.

  • Prelude Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2015 after selling out during the quarter.
  • Prelude Capital Management sold 5,000 BIO-REFERENCE LABS INC-NEW- shares in Q1 2015, an estimated $169K.
  • Prelude Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2013 and held it in 3 quarters.
  • Prelude Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $161K in Q4 2014.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2015.

Based on Prelude Capital Management's 13F filing for Q1 2015, filed 15 May 2015.